iZafe Group AB (publ) (STO:IZAFE.B)
Sweden · Delayed Price · Currency is SEK 0.3630
-0.0110 (-2.94%)
Jul 20, 2026, 4:34 PM CET
iZafe Group AB Revenue
iZafe Group AB had revenue of 2.43M SEK in the quarter ending March 31, 2026, with 40.78% growth. This brings the company's revenue in the last twelve months to 8.33M, up 11.54% year-over-year. In the year 2025, iZafe Group AB had annual revenue of 7.63M, down -20.20%.
Revenue (ttm)
8.33M
Revenue Growth
+11.54%
P/S Ratio
22.04
Revenue / Employee
644.73K
Employees
11
Market Cap
156.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.63M | -1.93M | -20.20% |
| Dec 31, 2024 | 9.56M | 6.16M | 181.47% |
| Dec 31, 2023 | 3.40M | 2.54M | 298.47% |
| Dec 31, 2022 | 852.00K | 476.00K | 126.60% |
| Dec 31, 2021 | 376.00K | -23.13M | -98.40% |
| Dec 31, 2020 | 23.50M | 9.17M | 64.03% |
| Dec 31, 2019 | 14.33M | 6.75M | 89.17% |
| Dec 31, 2018 | 7.57M | 6.92M | 1,056.34% |
| Dec 31, 2017 | 655.00K | - | - |
| Dec 31, 2016 | 0 | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AddLife AB | 10.53B |
| Synsam AB | 7.13B |
| Dynavox Group AB | 2.47B |
| Bonesupport Holding AB | 1.29B |
| Stille AB | 617.41M |
| Bio-Works Technologies AB | 82.85M |
| Ortivus AB | 76.75M |
| S2Medical AB | 16.13M |
iZafe Group AB News
- 2 months ago - iZafe Group AB Quarterly report: Q1 2026 - Filings
- 5 months ago - iZafe Group AB Quarterly report: Q3 2025 - Filings
- 5 months ago - iZafe Group AB Annual report: Q4 2025 - Filings
- 5 months ago - iZafe Group AB Quarterly report: Q4 2025 - Filings
- 9 months ago - iZafe Group AB Quarterly report: Q3 2025 - Filings
- 11 months ago - iZafe Group AB Quarterly report: Q2 2025 - Filings